Sevoflurane and thiopental preconditioning attenuates the migration and activity of MMP-2 in U87MG glioma cells

被引:34
作者
Hurmath, Fathima Kamaluddin [1 ]
Mittal, Mohit [2 ]
Ramaswamy, Palaniswamy [1 ]
Rao, G. S. Umamaheswara [2 ]
Nanjaiah, Nandakumar Dalavaikodihalli [1 ]
机构
[1] Natl Inst Mental Hlth & Neuro Sci NIMHANS, Dept Neurochem, Bengaluru 560029, Karnataka, India
[2] Natl Inst Mental Hlth & Neuro Sci NIMHANS, Dept Neuroanaesthesia, Bengaluru 560029, Karnataka, India
关键词
Glioblastoma; Anesthetics; Migration; Matrix metalloproteinases; NF-KAPPA-B; CANCER-CELLS; IN-VITRO; MATRIX METALLOPROTEINASES; CORTICAL DEVELOPMENT; ANESTHETIC TECHNIQUE; NMDA RECEPTOR; BRAIN-TUMORS; STEM-CELLS; ACTIVATION;
D O I
10.1016/j.neuint.2016.02.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Tumor cell migration and diffuse infiltration into brain parenchyma are known causes of recurrence after treatment in glioblastoma (GBM), mediated in part by the interaction of glioma cells with the extracellular matrix, followed by degradation of matrix by tumor cell derived proteases, particularly the matrix metalloproteinases (MMP). Sevoflurane and thiopental are anesthetics commonly used in cancer surgery. However, their effect on the progression of glioma cells remains unclear. The aim of this study was to explore the role of these anesthetics on the migration and activity of MMP-2 in glioma cells. Methodology: Cultured U87MG cells were pretreated with sevoflurane or thiopental and in vitro wound healing scratch assay was carried out to analyze their effect on migration of these cells. Gelatin zymography was carried out to examine the effect of these anesthetics on tumor cell MMP-2 activity using the conditioned media 24 h after pretreatment. Cell viability was analyzed using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTL) assay. Results: U87MG cells exposed to 2.5% sevoflurane or different concentrations of thiopental significantly decreased migration and activity of MMP-2 compared to control. No effect was seen on the viability of these cells after pretreatment with sevoflurane or thiopental. Conclusion/significance: These results suggest that both sevoflurane and thiopental have inhibitory effect on the migration and MMP-2 activity in glioma cells. Thus, it is important that the choice of anesthetics to be used during glioma surgery takes into account their inhibitory properties against the tumor cells. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:32 / 38
页数:7
相关论文
共 73 条
[1]   Effects of pre- and postischemic administration of thiopental on transmitter amino acid release and histologic outcome in gerbils [J].
Amakawa, K ;
Adachi, N ;
Liu, KY ;
Ikemune, K ;
Fujitani, T ;
Arai, T .
ANESTHESIOLOGY, 1996, 85 (06) :1422-1430
[2]  
[Anonymous], 2015, PLoS ONE
[3]   Minimum alveolar concentration: ongoing relevance and clinical utility [J].
Aranake, A. ;
Mashour, G. A. ;
Avidan, M. S. .
ANAESTHESIA, 2013, 68 (05) :512-522
[4]   Xenon decreases cell migration and secretion of a pro-angiogenesis factor in breast adenocarcinoma cells: comparison with sevoflurane [J].
Ash, S. A. ;
Valchev, G. I. ;
Looney, M. ;
Mhathuna, A. Ni ;
Crowley, P. D. ;
Gallagher, H. C. ;
Buggy, D. J. .
BRITISH JOURNAL OF ANAESTHESIA, 2014, 113 :14-21
[5]   RETRACTED: MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells (Retracted Article) [J].
Badiga, Aruna Venkata ;
Chetty, Chandramu ;
Kesanakurti, Divya ;
Are, Deepthi ;
Gujrati, Meena ;
Klopfenstein, Jeffrey D. ;
Dinh, Dzung H. ;
Rao, Jasti S. .
PLOS ONE, 2011, 6 (06)
[6]   Expression of matrix metalloproteinases and their inhibitors in human brain tumors [J].
Béliveau, R ;
Delbecchi, L ;
Beaulieu, E ;
Mousseau, N ;
Kachra, Z ;
Berthelet, F ;
Moumdjian, R ;
Del Maestro, R .
ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN, 1999, 886 :236-239
[7]  
Borgeat Alain, 2012, ANESTHESIOLOGY, V117, P293
[8]  
Camphausen K, 2001, CANCER RES, V61, P2207
[9]  
Choe GY, 2002, CLIN CANCER RES, V8, P2894
[10]   Excisional surgery for cancer cure: therapy at a cost [J].
Coffey, JC ;
Wang, JH ;
Smith, MJF ;
Bouchier-Hayes, D ;
Cotter, TG ;
Redmond, HP .
LANCET ONCOLOGY, 2003, 4 (12) :760-768